Device typeAcute myeloid leukaemia (AML) genetic mutation IVD, probe: A defined piece of single-stranded nucleic acid which is used to identify specific complementary-sequence nucleic acid molecules in an assay intended to be used to evaluate a clinical specimen to diagnose, monitor or predict acute myeloid leukaemia (AML) based on changes at the gene or chromosomal level which may include FLT3 gene mutations, NPM1 gene mutations, t(8;21), inv(16) and/or t(15;17).
FDA categoryEarly growth response 1 (egr) fish probe kit
Device ID00884999008366
Catalog number04N37-020
AvailabilityPrescription
Single useYes
MRI safetyLabeling does not contain MRI Safety Information